P2Y12 inhibitors for the neurointerventionalist.
R Hickman, Charlotte
Tan, Benjamin Yq
D Makalanda, Hegoda L
MetadataShow full item record
Borchert, R. J., Simonato, D., R Hickman, C., Fuschi, M., Thibault, L., Henkes, H., Fiorella, D., et al. (2022). P2Y12 inhibitors for the neurointerventionalist.. Interv Neuroradiol, 28 (1), 92-103. https://doi.org/10.1177/15910199211015042
The use of antiplatelets is widespread in clinical practice. However, for neurointerventional procedures, protocols for antiplatelet use are scarce and practice varies between individuals and institutions. This is further complicated by the quantity of antiplatelet agents which differ in route of administration, dosage, onset of action, efficacy and ischemic and hemorrhagic complications. Clarifying the individual characteristics for each antiplatelet agent, and their associated risks, will increasingly become relevant as the practice of mechanical thrombectomy, stenting, coiling and flow diversion procedures grows. The aim of this review is to summarize the existing literature for the use of P2Y12 inhibitors in neurointerventional procedures, examine the quality of the evidence, and highlight areas in need of further research.
Reviews, Antiplatelets, hemorrhage, stroke, aneurysm, thrombectomy
External DOI: https://doi.org/10.1177/15910199211015042
This record's URL: https://www.repository.cam.ac.uk/handle/1810/334778